New aspects of vaccine development.
Liew
F Y
FY
D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D000917:Antibody Formation; D005537:Aphthovirus / Q000276:immunology; D001427:Bacterial Toxins / Q000276:immunology; D004274:DNA, Recombinant; D000939:Epitopes / Q000276:immunology; D004927:Escherichia coli Infections / Q000517:prevention & control; D005818:Genetic Engineering; D006168:Guinea Pigs; D006801:Humans; D007111:Immunity, Cellular; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D008262:Macrophage Activation; D051379:Mice; D010455:Peptides / Q000138:chemical synthesis; D011487:Protein Conformation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014616:Vaccinia virus / Q000276:immunology
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D004274:DNA, Recombinant; D000939:Epitopes; D007130:Immunoglobulin Idiotypes; D010455:Peptides; D014612:Vaccines; D014613:Vaccines, Attenuated